Purpose: To calculate organ S values (mGy/Bq-s) and effective doses per time-integrated activity (mSv/Bq-s) for pediatric and adult family members exposed to an adult male or female patient treated with I-131 using a series of hybrid computational phantoms coupled with a Monte Carlo radiation transport technique. Methods: A series of pediatric and adult hybrid computational phantoms were employed in the study. Three different exposure scenarios were considered: (1) standing face-to-face exposures between an adult patient and pediatric or adult family phantoms at five different separation distances; (2) an adult female patient holding her newborn child, and (3) a 1-yr-old child standing on the lap of an adult female patient. For the adult patient model, two different thyroid-related diseases were considered: hyperthyroidism and differentiated thyroid cancer (DTC) with corresponding internal distributions of 131 I. A general purpose Monte Carlo code, MCNPX v2.7, was used to perform the Monte Carlo radiation transport.
INTRODUCTION
In the Society of Nuclear Medicine and Molecular Imaging (SNMMI) procedure guideline 1 for radioiodine therapy, common methods to prescribe the amount of I-131 activity have been introduced. For the patients treated for hyperthyroidism, one may use the size of thyroid gland and the results of a 24-h I-131 uptake test. Based on these SNMMI guidelines, an activity in the range of 2775-5550 MBq (75-150 mCi) is generally administered for the ablation of the thyroid bed remnants following thyroidectomy for thyroid cancer patients. For differentiated metastatic thyroid cancer (DTC) patients, there are two common approaches to determine the administered I-131 activity. The first approach is an empirical fixed-activity paradigm where 7400 MBq (200 mCi) is given to all cancer patients. The second approach is a dosimetric scheme that estimates the absorbed dose to bone marrow based on serial blood and whole-body counting to ensure that the dose does not exceed 2 Gy. 2, 3 Using the second approach, the prescribed activity could be more than 7400 MBq (200 mCi).
After I-131 is administered to a patient, licensees can release the patient if they can confirm that the effective dose (the regulation in the US specifically refer to the TEDE, and it is defined as the total effective dose equivalent) to any other individual exposed to the patient is not likely to exceed 5 mSv based on the following equation recommended in 10 CFR Part 35.75:
where D is the total dose from exposure to gamma radiation, 34.6 is the conversion factor of 24 h/day multiplied by the total integration of decay (1.44), (mGy-m 2 /Bq-s) is the exposure rate constant for a point source, Q o (MBq) is the administered activity, T p (days) is the physical half-life of the radionuclide, r is the distance from the point source to the point of interest in meters, and OF is the occupancy factor, which represents the fraction of total time that an individual spends at a distance of r (i.e., 1 m) from the patient.
The intrinsic conservatism underlying Eq. (1) has been underscored in several previous studies. Siegel et al. 5 found that the point source method is not suitable up to a certain distance between radioactive patients and exposed family members. Sparks et al. 2 reported that the point source method overestimates dose equivalent per time-integrated activity by more than a factor of 2. Han et al. 3 calculated the maximum releasable activity under the regulatory limit and effective dose per time-integrated activity using a series of the revised Oak Ridge National Laboratory (ORNL) stylized phantoms 6 as a function of distance, for two different exposure scenarios and three different types of distributions of I-131. The authors reported that the overestimation of the point source/target method as compared to anthropomorphic phantom-based calculations is more than twofold. The overestimation may be caused by the assumption that the human body involved in the exposure scenario was simulated as a point in space, which ignores photon attenuation and scattering in both patient and exposed family members. The built-in conservatism in the Nuclear Regulatory Commission (NRC) formation, thus, may result in an unnecessary increase of the length of patient's stay in the hospital. Although these previous studies 2, 3 used more realistic approaches--modeling patient and family member using stylized computational phantoms-these phantoms are still limited in their ability to accurately represent human anatomy, as the organs in stylized phantoms are described by simple mathematical surface equations such as planes, cylinders, cones, ellipsoids, and spheres.
There have been some efforts to overcome the anatomical limitations of the stylized phantoms in the simulations of the patient-to-family member through the use of voxel phantoms based on patient CT images. de Carvalho et al. 7 reported organ and effective doses for a caregiver or bystander exposed to a radioactive patient using two standing adult female voxel phantoms at three different separation distances and orientations. More recently, they reported the dose to the exposed individuals from three therapeutic regions represented by point, line, and volume source models, and they emphasized the conservatism inherent in the point source model. 8 In the present study, we simulated the conventional faceto-face exposure scenario as well as more realistic scenario, including a baby/child exposed to its radioactive mother while the mother is closely holding the baby. Zanzonico et al. reported the measured dose rate based algorithm to determine the time of release and the duration of postrelease precautions such as a patient not holding a child after radioiodine therapy. They used a distance of 0.3 m for the child held by the patient and 1 mSv as the maximum permissible effective dose to pediatrics and pregnant women and their work was also included in NCRP Report No. 155. 9, 10 To perform the realistic exposure simulations, we employed a series of hybrid phantoms developed in collaboration between the University of Florida (UF) and the National Cancer Institute (NCI), which can be easily morphed into realistic postures. Organ S values and effective doses per time-integrated activity to pediatric and adult family members exposed to adult male or female patients were calculated by coupling the hybrid phantom series with a Monte Carlo radiation transport technique. The results were compared with the US NRC regulatory limit and the values we previously reported using stylized phantoms.
METHODS

2.A. UF/NCI hybrid phantom series
In this study, we employed the UF/NCI hybrid phantom series including the newborn, 1-, 5-, and 10-yr-old male phantoms, and 15-yr-old and adult male and female phantoms. The original Non-Uniform Rational B-Spline (NURBS) and Polygon Mesh (PM) format of the phantoms was converted into voxel format using a procedure called voxelization for Monte Carlo radiation transport. The adult male and female phantoms representing patients treated with I-131 were voxelized at the resolution of 3 mm 3 , whereas the pediatric and adult phantoms representing family members exposed to the patients were voxelized at the resolution of 2 mm 3 , with an exception of the newborn and 1-yr-old male phantoms which were voxelized at the resolution of 1 mm 3 to better describe the details of their organs and skeletal structure. Only male phantoms were used for pediatric family phantoms from newborn to 10-yr-old as their anatomy is identical to that of female phantoms with the exception of the genderspecific organs. The heights of the phantoms are 76 cm (1-yr-old), 109 cm (5-yr-old), 138 cm (10-yr-old), 161 cm (15-yr-old female), 167 cm (15-yr-old male), 163 cm (adult female), and 176 cm (adult male).
2.B. Patient-to-family exposure scenario
One conventional and two more realistic exposure scenarios were considered in this study. First, conventional exposure scenarios were simulated where the released adult male or female patient is facing family members (1-, 5-, and 10-yr-old male, 15-year-old male and female, and adult male and female) at five different separation distances (10, 50, 75, 100, and 200 cm). Figure 1 shows the lateral views of the adult male patient phantom facing the 1-, 5-, 10-, and 15-yr-old male family phantoms at different distances.
Second, two additional scenarios were simulated including (a) a radioactive mother cuddling a newborn baby (distance from the mother's neck to the baby's abdomen is 18 cm) and (b) 1-yr-old child standing on the mother's lap (distance from abdomen to abdomen is 13 cm) as shown in Fig. 2 . The original NURBS/PM files of the newborn and 1-yr-old phantoms were merged with that of the adult female phantom within the 3D NURBS/PM modeling software, Rhinoceros TM (McNeel, Seattle, WA). The arms, legs, and head of the adult female phantom including skeleton were reoriented to represent the different postures shown in Fig. 2 . The mother and baby phantoms in NURBS/PM format were voxelized together to be implemented in Monte Carlo transport simulation. The previous organ and tissue in the female phantom were adjusted to avoid conflict with the baby and child phantoms.
2.C. Modeling of the source distribution
Two I-131 source distributions were considered to represent the two main types of treatments: hyperthyroidism and metastatic differentiated thyroid cancer (DTC). First, the 
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source region for hyperthyroid-patient was the thyroid gland, given that the thyroid gland may demonstrate an uptake of the order of 80% or more of available circulating radioiodine in hyperthyroid-patients. 11, 12 A thyroid source distribution is also applicable to the approximation of radioiodine uptake in the postoperative thyroid gland remnant in patients undergoing I-131 remnant ablation after thyroidectomy or in patients with residual iodine-avid metastatic lymph node involvement within the neck.
Second, patients with DTC who have undergone total or near-total thyroidectomy typically have a neck I-131 uptake of less than 5% of the administered activity, with metastases most frequently appearing in the lungs (49% of metastases), skeleton (25%), or both (15%). 16 Thus, in order to be conservative, the source regions for simulating DTC included all sites of significant iodine localization such as the lungs, thyroid bed (simulating the gland remnants or neck lymph nodes), salivary glands, stomach (contents and wall), small intestine (contents and wall), colon (contents and wall), liver, kidneys, and urinary bladder (contents and wall). 11 We excluded bone metastases in this study because they may occur randomly throughout the whole body. 13 The I-131 photon spectrum reported by International Commission on Radiological Protection (ICRP) Publication No. 107 was employed in the Monte Carlo simulation. 14 In both source definitions, we first extracted the location of voxels tagged with the index of the source organ (or organs for DTC source) from the patient phantoms. Then we randomly sampled a voxel location from the series of extracted voxel locations of the source organs. The source voxel was uniformly sampled within a single organ (e.g., the thyroid source). However, as for the DTC source, the sampling was technically weighted by the size of the source organs so that the bigger the organ was the more sampling was conducted. This approach, thus, implicitly assumes a uniform activity concentration of I-131 in all source tissues for the DTC patient scenarios. The approach can, thus, be altered given clinically relevant biokinetic models of I-131 for cancer patients.
2.D. Monte Carlo radiation transport
We used a general purpose Monte Carlo transport code, MCNPX v2.7, 15 for the simulations of the exposure scenarios. The UF/NCI hybrid phantoms in voxel format were implemented in the MCNPX code. Reference elemental compositions and mass densities were obtained from the International Commission on Radiation Units and Measurements (ICRU) Report No. 46 (Ref. 16 ) and ICRP Publication No. 89, 17 and were implemented in the MCNPX material cards.
In the face-to-face exposure scenarios, particle tracks and energy information at a virtual planar surface positioned in front of the patient phantom were first recorded in the file (called as a "phase-space file"). The file was then subsequently sampled to continue the transport of emitted photons to the various family phantoms located at different distances from the patient phantom. For the two mother-child exposure scenarios, direct photon transport from mother to child was simulated. Kerma approximation was used when calculating organ average doses considering the energy of 364 keV for the primary photons of I-131. In order to ensure the applicability of the approximation, we evaluated differences of organ S values within various target phantoms calculated using the kerma approximation as well as using full secondary electron transport. The differences were less than 2% with the exception of small organs in which the differences were still less than 5%.
To calculate dose to the active marrow and bone endosteum (shallow marrow), recently published fluence-to-dose response functions 18 developed at the University of Florida were adopted. Energy-dependent photon fluence to the spongiosa volume in a total of 34 bone sites was scored in 25 energy bins ranging from 0.01 to 10 MeV. Active marrow and endosteum doses in each bone site were then calculated as the energy-summed product of the photon fluences and the fluence-to-dose response functions for active marrow and endosteum, respectively. Skeletal averaged active marrow and endosteum doses were calculated as target mass-weighted average of the bone-specific doses.
A total of 500 million photon histories were used to decrease the relative errors within the major organs of the family phantoms to less than 2%, with the exception of small organs such as the prostate, testes, adrenals, and gall bladder, which showed relative errors up to 3% for the adult and 15-yr-old family phantoms. Organ doses in the pediatric family phantoms showed a relative error of less than 3% (10-yrold) and 5% (5-yr-old). Since the height of the 1-yr-old phantom (76 cm) is much shorter than the height of both source regions, the relative errors of major organ doses were up to 10%.
2.E. Calculation of S values and effective dose per time-integrated activity
The MIRD dosimetry schema 19 shown in Eq. (2) was modified to calculate the absorbed dose and effective dose to target phantoms by replacing the target organ r T with an organ in family phantoms, r FM,T , and replacing the source organ r S within patient phantoms, r PT , as shown in Eq. (3):
whereÃ P T is a total time-integrated activity in the source region of patient phantoms and S(r FM, T ← r PT ) is the mean absorbed (or equivalent) dose to a target region within family phantoms per time-integrated activity (mGy/Bq-s). The effective dose for each family phantom was calculated as a summation of the organ equivalent doses in family phantoms multiplied by tissue weighting factors reported in ICRP Publication No. 103. 20 Equation (3) may be expanded to show the details
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of the S value calculation:
where E i is the emitted photon energy from I-131, Y i is the radiation yield of the ith photon, m T is the target organ mass (kg), and ϕ(r FM, T ← r PT ) i is the absorbed fraction defined as the fraction of radiation energy emitted from a source region in the patient phantom that is deposited in a given organ in the exposed family phantom. It is assumed that the sum of the w T -weighted organ doses for the 1-, 5-, and 10-yr-old male phantoms is a reasonable estimation of the gender-averaged effective dose which is recommended by ICRP Publication No. 103.
RESULTS AND DISCUSSIONS
Organ-specific S values (mGy/Bq-s) and effective dose per unit time-integrated activity (mSv/Bq-s) were calculated for pediatric and adult family phantoms (1-, 5-, and 10-yrold male phantoms and 15-yr-old and adult male and female phantoms) facing the adult male and female patients. The   FIG. 3 . S values (mGy/Bq-s) to the (a) lungs and (b) active marrow of family phantoms from the adult male hyperthyroid-patient phantom as a function of distance.
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values were also calculated for more realistic exposure scenarios of the adult female phantom closely holding the newborn or 1-yr-old male phantoms. Two different I-131 distributions, characteristic of hyperthyroidism and DTC, were simulated within both the adult male and female patient phantoms. Illustrative dose comparisons were presented for lungs and active marrow for hyperthyroid-patient source and colon and active marrow for DTC-patient source because of their relatively high tissue weighting factor, 0.12, in ICRP Publication No. 103.
3.A. Hyperthyroid-patient source
Figures 3(a) and 3(b) shows the age-dependent S values (mGy/Bq-s) to lungs and active marrow, respectively, in the family phantoms when exposed to the adult male hyperthyroid-patient phantom as a function of distance. S values decrease rapidly with increasing interphantom distances and converge to a single value at the distance of 2 m. The S values show a strong dependency on the age and organs of the family phantoms at shorter distance beyond which the dependency decreases following the inverse square law. The 1-and 5-yr-old phantoms are relatively less exposed to the radiation from the adult patient phantom in the face-to-face exposure scenario due to their shorter heights as compared to the older and larger family phantoms.
Figures 4(a) and 4(b)
show the S values to lungs and active marrow, respectively, in the family phantoms when exposed to the adult female hyperthyroid-patient. A similar trend to Fig. 3 is observed with the exception that the S values to the lungs from the adult female [ Fig. 4(a) ] are higher by 1.6 fold than the values from the adult male at distances less than 50 cm. S values to the active marrow from the adult female [ Fig. 4(b) ] are higher by a factor of 1.4. This is attributed to the fact that the location of thyroid source is lower in the adult female phantom than the adult male so that the distance from the adult female source (thyroid) to target phantoms is shorter than that from the adult male phantom to family phantoms.
Effective doses per time-integrated activity (mSv/MBq-s) for the 1-, 5-, 10-, 15-yr-old and adult phantoms are shown in Fig. 5 as a function of distance when the I-131 distribution of the hyperthyroidism adult male and female patient phantoms is simulated. The solid and dotted lines represent the values for the adult male and female patient phantoms, respectively. At the distance of 10 cm, the effective doses to the 15-yr-old and adult phantoms are highest, showing that the height of the family phantoms greatly impacts the effective dose in the case of the hyperthyroid-patient source. The values from the adult female hyperthyroid-patient are up to a factor of 1.5 higher (5-and 10-yr-old) than those from the adult male patient.
The value recommended by NRC (based on the point source/target method at 1 m distance) is displayed as a horizontal solid line for comparison in Fig. 5 . At the distance of 1 m, effective doses from both adult male and female are lower than the NRC value by factors of 2.0, 1.6, 1.5, and 1.6 for the exposed 5-, 10-, 15-yr-old and adult phantoms, respectively. If an activity of 50 mCi is administered to a hyperthyroidism adult male patient, the effective dose to a 10-yr-old child spending most of the time at the distance of 1 m with the adult male patient will be 4.7 mSv, whereas the value based on the NRC point source/target method [Eq. (1)] will be 7.7 mSv, which means that the patient cannot be released right after radioiodine treatment. The effective dose at the distance of 2 m is very close to the value from the point source/target method if 2 m is used in the calculation instead of 1 m regardless of the ages of the family phantoms and the type of the treatments, which suggests that the point source/target method is still valid at 2 m.
We reported a similar trend of the age-dependent effective dose values in our previous study which was based on stylized phantoms for both source and target phantoms. 3 Effective doses per time-integrated activity to the 5-, 10-, 15-yr-old, and adult hybrid phantoms were higher than the values from the stylized phantoms at the corresponding age by factors of 2.3, 2.7, 1.9, and 1.6, respectively, at the separation distance of 10 cm when the I-131 is localized in the thyroid of the adult male patient phantom. The differences are attributed to the more realistic body contour of the hybrid phantoms as compared to those of the stylized phantoms in which the anterior body contour is flat from the top to the bottom of the torso.
3.B. DTC patient source
Figures 6 and 7 show the S values (mGy/Bq-s) to the (a) colon and (b) active marrow of the pediatric and adult family phantoms exposed to the adult male and female patient phantoms, respectively, when the I-131 distribution for the DTC patient is simulated. The overall behavior of the S values is similar to the values for the hyperthyroid-patients (Figs. 3 and 4) where the values to the 1-yr-old phantom again are relatively small as compared to those to other older family phantoms. The active marrow of the 10-and 5-yr-old phantoms shows the first and second highest S values in Fig. 7(b) .
The S values from the adult female DTC patient phantom (Fig. 7 ) are up to a factor of 1.6 higher than the values from the adult male phantom (Fig. 6 ). Figure 8 shows effective doses per time-integrated activity (mSv/MBq-s) to the 1-, 5-, 10-, and 15-yr-old and adult phantoms from the adult male and female DTC patient phantoms as a function of distance. The 10-and 15-yr-old phantoms show the highest values because the locations of major organs in those phantoms contributing to effective dose are at the similar level of the source regions in the DTC patient phantoms. At the distance of 10 cm, the values for the adult female DTC patient phantom are higher than those from the adult male by a factor of up to 1.5 (1-yrold). The values are lower than the NRC-recommended value by factors of 2.3, 2.0, 2.0, and 2.2 for the exposed 5-, 10-, 15-yr-old, and adult phantoms, respectively, at the distance of 1 m. Effective doses that we previously reported using the stylized phantoms are higher than the values in the current study by a factor of up to 1.8 at the distance of 10 cm. It is, however, difficult to perform a fair comparison between the two results because the source definitions are completely different between the two calculations. The source region in the stylized phantom was designed across the whole lower abdominal volume with the dimension of 35 (height) × 33 (width) × 20 (length) cm 3 following the definition used by Sparks et al. 2 However, the source region within the hybrid adult male phantom is distributed throughout the abdomen with the dimension of 75.5 (height) × 28.5 (width) × 19.4 (length) cm 3 as previously described in Sec. 2.C. Figure 9 shows (a) S values (mGy/Bq-s) of four major organs and tissues (colon, lungs, stomach, and active marrow) on a logarithmic scale and (b) effective dose per unit timeintegrated activity (mSv/Bq-s) in the newborn and 1-yr-old phantoms that are realistically positioned with the adult female patient phantom as shown in Fig. 2 . S values of the organs in the newborn phantom from the hyperthyroid-patient phantom are higher than the values from the DTC patient phantom by factors of 1.1, 1.4, 1.4, and 1.2 for colon, lungs, stomach, and active marrow, respectively. Effective dose per unit time-integrated activity to the newborn phantom from the hyperthyroid-patient is 1.3 higher than the value from the DTC patient. This is attributed to the fact that most of the major organs in the newborn phantom are directly irradiated by the hyperthyroid-patient source rather than the DTC-patient source which is distributed across the abdominal region, as shown in Fig. 2(a) .
3.C. Realistic exposure scenario of mother and baby
S values and effective dose per time-integrated activity to the 1-yr-old baby phantom from the hyperthyroid-patient are higher than those from the DTC patient by factors of 1.2, 2.6, 1.9, 2.1, and 1.9 for colon, lungs, stomach, active marrow, and effective dose, respectively, for the same reasons as discussed above.
The trend in S values and effective dose per time-integrated activity calculated using the realistic exposure scenarios of mother and babies shown in Fig. 2 are not observed in the simplified exposure geometry shown in Fig. 1. 
CONCLUSIONS
We evaluated organ S values and effective dose per timeintegrated activity to pediatric and adult family members exposed to adult male or female patients treated with I-131 for hyperthyroidism and DTC using Monte Carlo radiation transport methodology. In addition to the conventional face-to-face geometry that has been studied by previous authors, more realistic exposure scenarios involving babies exposed to a radioactive mother patient were simulated for the first time using position morphed hybrid phantoms.
Overall, S values show a strong dependency on the given target organ and the age of target family phantoms relative to the source region as defined in the adult male and female patient phantoms. S values from the adult female patient phantom are higher by a factor of 1.6 than the values from the adult male at shorter distance and in younger family phantoms. Effective doses per time-integrated activity based on anatomically realistic hybrid phantoms are lower by twofold than the values of NRC recommendations. The realistic exposure scenario of a radioactive mother holding a baby revealed that the effective dose per unit time-integrated activity to the newborn and 1-yr-old phantoms from the hyperthyroid-patient phantom is higher than the value from the DTC patient which was not be observed in the simplified face-to-face exposure geometries.
In this study, we reconfirmed the significant conservatism underlying the point source/target method recommended by the NRC. The study also revealed that the exposures of 10-and 15-yr-old children were higher than those in younger children because major organs in those phantoms are distributed at the similar level with the hyperthyroidism and DTC-patient sources. Therefore, it might be helpful to provide licensees with a conversion factor of dose rate measurement at 1 m from the patient to age-specific effective doses to family members in the realistic exposure scenarios. Also, the current study will be expanded to the effective dose-based guideline for a site physicist to determine the time of patient release and the duration for radiation precaution to family members.
Since the results also showed that the radiation exposure to the family member strongly depends on the I-131 distribution within the patient, current efforts in our research groups will explore similar studies using patient-specific voxel phantoms and more realistic activity distributions based on SPECT-CT images. In the meantime, the results of this study may be used to better inform physicians and hospital staff on recommendations for patient release following radioiodine therapies.
